Immunohistochemical detection of WT1 protein in a variety of cancer cells-Reference-Cited by-同舟云学术

Immunohistochemical detection of WT1 protein in a variety of cancer cells

Published:2006-03-17 Issue:6 Volume:19 Page:804-814
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Nakatsuka Shin-ichi,Oji Yusuke,Horiuchi Tetsuya,Kanda Takayoshi,Kitagawa Michio,Takeuchi Tamotsu,Kawano Kiyoshi,Kuwae Yuko,Yamauchi Akira,Okumura Meinoshin,Kitamura Yayoi,Oka Yoshihiro,Kawase Ichiro,Sugiyama Haruo,Aozasa Katsuyuki

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800588.pdf

Reference37 articles.

1. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 1990;60:509–520.

2. Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990;343:774–778.

3. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys–Drash syndrome. Cell 1991;67:437–447.

4. Pelletier J, Bruening W, Li FP, et al. WT1 mutations contribute to abnormal genital system development and hereditary Wilms’ tumour. Nature 1991;353:431–434.

5. Little MH, Prosser J, Condie A, et al. Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 1992;89:4791–4795.

Cited by 252 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Wilms’ tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed;Annals of Hematology;2024-09-11

2. Super-enhancer-drivenCACNA2D2is an EWSR1::WT1 signature gene encoding a diagnostic marker for desmoplastic small round cell tumor (DSRCT);2024-07-21

3. Spontaneous high clonal expansion of Wilms’ tumor gene 1 (WT1)-specific cytotoxic T-lymphocytes in patients with WT1-expressing solid tumor;2024-06-13

4. Adjuvant Wilms’ tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium;BMJ Open;2024-03

5. Wilms’ tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP;PLOS Pathogens;2024-01-08